Verition Fund Management
CNMD icon

Verition Fund Management’s CONMED CNMD Stock Holding History

Verition Fund Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Sell
7,940
-5,060
-39% -$206K ﹤0.01% 1801
2025
Q4 		$528K Sell
13,000
-9,096
-41% -$396K ﹤0.01% 2617
2025
Q3 		$1.04M Sell
22,096
-1,067
-5% -$55.3K ﹤0.01% 2511
2025
Q2 		$1.21M Buy
+23,163
New +$1.27M 0.01% 2334
2025
Q1 		– Sell
-7,005
Closed -$479K – 3377
2024
Q4 		$479K Buy
7,005
+3,826
+120% +$267K ﹤0.01% 2511
2024
Q3 		$229K Sell
3,179
-13,845
-81% -$977K ﹤0.01% 2802
2024
Q2 		$1.18M Sell
17,024
-41,502
-71% -$3.03M 0.01% 1569
2024
Q1 		$4.69M Buy
+58,526
New +$5.22M 0.03% 718
2022
Q3 		– Sell
-7,807
Closed -$748K – 3062
2022
Q2 		$748K Buy
+7,807
New +$937K 0.01% 1192
2021
Q4 		– Sell
-40,304
Closed -$5.27M – 2580
2021
Q3 		$5.27M Sell
40,304
-27,834
-41% -$3.64M 0.05% 268
2021
Q2 		$9.36M Buy
68,138
+2,605
+4% +$357K 0.09% 141
2021
Q1 		$8.56M Buy
65,533
+5,074
+8% +$611K 0.1% 127
2020
Q4 		$6.77M Buy
60,459
+11,825
+24% +$1.12M 0.06% 172
2020
Q3 		$3.83M Sell
48,634
-368
-0.8% -$30K 0.08% 153
2020
Q2 		$3.53M Buy
49,002
+3,575
+8% +$249K 0.12% 142
2020
Q1 		$2.6M Buy
45,427
+10,297
+29% +$950K 0.1% 135
2019
Q4 		$3.93M Buy
35,130
+12,415
+55% +$1.32M 0.07% 173
2019
Q3 		$2.18M Buy
22,715
+1,922
+9% +$180K 0.06% 231
2019
Q2 		$1.78M Buy
+20,793
New +$1.71M 0.05% 267

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Verition Fund Management's CNMD Position: Q1 2026 in Review

Verition Fund Management reduced its CONMED (CNMD) stake by 39% in Q1 2026, selling an estimated $206K and leaving 7,940 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

Verition Fund Management first reported a position in CNMD in Q2 2019 and has held it in 19 quarters since. The position peaked at $9.36M in Q2 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Verition Fund Management held 7,940 shares of CONMED worth $281K as of Q1 2026.
  • Verition Fund Management sold 5,060 CONMED shares in Q1 2026, an estimated $206K.
  • CONMED made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1801 holding.
  • Verition Fund Management first reported a position in CONMED in Q2 2019 and has held it in 19 quarters since.
  • Verition Fund Management's CONMED position peaked at $9.36M in Q2 2021.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.